Stockholders’ Equity and Equity Incentive Plans (Tables)

6 Months Ended

Jul. 31, 2025

Equity [Abstract]

Schedule of Stock Option Activity Under Equity Incentive Plan

A summary of stock option activity under our equity incentive plan and related information is as follows:

	Stock Options
	Outstanding Stock Options	Weighted- Average Exercise Price	Weighted- Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value
	(in thousands, except share, life, and per share data)
Balance as of January 31, 2025	2,394,918	$9.02	2.6	$	187,284
Exercised	(471,770)	$2.91		$	36,642
Canceled/forfeited/expired	(4,488)	$94.87
Outstanding and exercisable as of July 31, 2025	1,918,660	$10.33	2.5	$	124,000

Schedule of Restricted Stock Units (RSUs) Activity Under Equity Incentive Plan

A summary of RSU activity under our equity incentive plan and related information is as follows:

	RSUs
	RSUs	Weighted- Average Grant Date Fair Value Per Share
Unvested as of January 31, 2025	23,870,513	$	73.48
Granted	5,161,763	$	75.12
Vested	(6,578,596)	$	76.26
Canceled/forfeited	(1,792,221)	$	72.42
Unvested as of July 31, 2025	20,661,459	$	73.14

Schedule of Stock-based Compensation Expense

The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows:

	Three Months Ended July 31,				Six Months Ended July 31,
	2025		2024		2025		2024
	(in thousands)
Cost of revenue	$	24,222	$	31,299	$	51,649	$	62,874
Research and development	70,476		81,597		143,412		164,166
Sales and marketing	63,094		84,225		131,527		161,459
General and administrative	30,907		40,829		63,680		78,876
Total stock-based compensation expense	$	188,699	$	237,950	$	390,268	$	467,375
Benefit from income taxes	(35,067)		(43,742)		(73,228)		(87,216)
Total stock-based compensation expense recorded to net income	$	153,632	$	194,208	$	317,040	$	380,159